Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INVA · against 588 other Healthcare companies listed in US-listed
Ranked #14 of 589 · scores higher than 97% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 90–100, including INVA · Click a bar to see the companies
Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | INVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 20.4% | -4.3% | 98% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 15.5% | -0.8% | 93% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 11.9% | -2.3% | 96% | 20% | |
| Book yieldHigher is better · 587 reported | 81.1% | 25.9% | 88% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 11 | 21.5B USD | 95 | 60 | |
| 11 | 609M USD | 95 | 91 | |
| 14 | 334M USD | 94 | 53 | |
| 14 | 11.6B USD | 94 | 58 | |
| 14 | 1.5B USD | 94 | 93 | |
| 14 | 914M USD | 94 | 81 | |
| 18 | 5.8B USD | 93 | 64 | |
| 18 | 261M USD | 93 | 97 | |
| 20 | 301M USD | 92 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score